Tonix Pharmaceuticals Holdings Corp. Closes $40M Common Stock Offering Priced At-the-Market Under Nasdaq Rules

    NEXT STORY
    SIGA Announces Public Health Agency of Canada Contract Award to Purchase Up To Approximately $33 Million of Oral TPOXX®
    PREV STORY
    Ayala Pharmaceuticals to Present at Noble Capital Markets 17th Annual Small & Microcap Virtual Investor Conference
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Change in the number of shares and votes in Oasmia Pharmaceutical AB (publ)

    Oasmia Pharmaceutical AB (publ) (”Oasmia” or ”Company” or “Group”) on 18 April 2018 issued ...

    author_avatar
    NASDAQ Market News

    Gateway Health to sponsor town hall meeting to address postpartum depression among Black women

    author_avatar
    NASDAQ Market News

    CRISPR-focused Excision BioTherapeutics Strengthens Board of Directors Appointing Veteran Pharmaceutical Executive Bill Carson, M.D.

    author_avatar
    NASDAQ Market News